Toxic delirium

DSM-V criteria

  • Disturbance in attention and awareness
  • Change in cognition that is not better accounted for by pre-existing, established or evolving dementia
  • Disturbance develops over hours to days and fluctuates
  • Evidence that disturbance is caused by direct a direct physiological consequence of a general medical condition, intoxicant or more than one cause

Resuscitation

  • ABC
  • Consider atypical or non-consulsive status as cause early and treat with benzos if suspected
  • Check BSL early
  • Check temperature and continously monitor if >38.5

Risk assessment

  • Must vigorously assess for:
    • Possible causes (toxicological)
    • Important complications
    • Alternative non-toxicological causes
    • Specific toxidromes that require specific interventions

Risk assessment

  • Toxicological differential
    • Alcohol
    • Anticholinergic delirium
    • Antidepressants (Bupropion, MAOi, venlafaxine)
    • Atypical antipsychotics
    • Baclofen
    • Benzo’s/zolpidem/zopiclone
    • Cannabis
    • Hallucinogenic agents
    • Neuroleptic malignant syndrome
    • Nicotine
    • Salicylates
    • Sympathomimetic syndrome
    • Theophylline
    • Withdrawal of benzo/alcohol/opioid

Risk assessment

  • Complications
    • Aspiration pneumonitis
    • DVT/PE
    • Fluid, electrolyte and acid-base disturbance
    • Hypoventilation/hypoxia
    • Hyperthermia
    • Physical injury
    • Rhabdomyolysis

Risk assessment

  • Mimics
    • Acid-base disturbance
    • Behavioural
    • CNS infection
    • Dementia
    • Electrolyte disturbance e.g. hyponatraemia
    • Endocrine emergency e.g. thyroid storm
    • Head injury
    • Hypoglycaemia
    • Hypoxia
    • Organ failure e.g. hepatic encephalopathy
    • Psychosis
    • Seizures (NCSE)
    • Stroke (INCL. POSTERIOR)
    • Trauma e.g. subdural heamorrhage)
    • Withdrawal

Risk assessment

  • Agents that may require specific intervention
    • Anticholinergics – Physostigmine
    • Neuroleptic malignant syndrome – Bromocriptine
    • Salicylates – Urinary alkalinisation +- dialysis
    • Serotonin syndrome – Cyproheptadine, paralysis I&V
    • Theophylline – MDAC +- haemodialysis

General supportive cares

  • Monitoring of airway and conscious state
  • Respiratory toilet and prophylaxis e.g. mobilisation/chest physio
  • Fluid monitoring
  • Bladder care
  • Prevention of pressure areas
  • DVT prophylaxis
  • Mobilisation as mental status changes

Last Updated on October 13, 2020 by Andrew Crofton